General Interest
Pediatric eye injuries by hydroalcoholic gel in the context of the Covid-19 Pandemic
12 Feb, 2021 | 02:12h | UTCCase series: Hand Sanitizer–Induced Ocular Injury: A COVID-19 Hazard in Children – JAMA Ophthalmology
Invited commentary: Unintended Consequences of Hand Sanitizer Use in the Coronavirus Disease 2019 Pandemic – JAMA Ophthalmology
Randomized, cross-over trial: Compared to Mediterranean diet, a Low-fat vegan diet is better at improving body weight, lipid concentrations, and insulin sensitivity
11 Feb, 2021 | 01:56h | UTC
Commentary on Twitter
36-week randomized cross-over trial:
💥Low-fat plant-based diet reduced body weight, fat mass, and visceral fat, increased insulin sensitivity, and improved blood lipids, compared with a Mediterranean diet.https://t.co/ROJX9WYcix
— Danielle Belardo, MD (@DBelardoMD) February 6, 2021
CDC Guidance: Improve the fit and filtration of your mask to reduce the spread of COVID-19
11 Feb, 2021 | 02:21h | UTC
CDC study on practical ways for maximizing fit for masks to reduce SARS-CoV-2 transmission and exposure
11 Feb, 2021 | 02:25h | UTCCommentaries: CDC Says Double-Masking Offers More Protection Against The Coronavirus – NPR AND CDC report: Double-masking can block more than 90 percent of viral particles – NBC News
Case report: Severe reinfection with South African SARS-CoV-2 variant
11 Feb, 2021 | 02:17h | UTC
Commentary on Twitter
🔥NEW Case report 🔥#CID @IDSAInfo
Severe reinfection with South African SARS-CoV-2 501Y.V2 lineage B.1.351 variant four months after a first mild infection. @InfectiousDz https://t.co/zjjJED4r0D— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) February 10, 2021
WHO experts recommend AstraZeneca COVID vaccine across all ages and countries
11 Feb, 2021 | 02:20h | UTCCommentaries: WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout – Health Policy Watch AND WHO backs use of Oxford/AstraZeneca Covid vaccine for adults of all ages – The Guardian AND Covid: WHO backs Oxford vaccine ‘even if variants present’ – BBC AND Expert reaction to WHO recommending use of the Oxford/AstraZeneca COVID-19 vaccine, including in over 65s – Science Media Centre AND Up Against Mutants, WHO Says AstraZeneca Vaccine Is Still A Good Bet – NPR
Perspective: Leave your antibodies alone
11 Feb, 2021 | 02:12h | UTCLeave Your Antibodies Alone – The Atlantic
SARS-CoV-2 seroprevalence study in daycare centers in France suggests low rates of infection in very young children
10 Feb, 2021 | 01:55h | UTC
Commentary on Twitter (thread – click for more)
NEW—Research assessing seroprevalence in daycare centres open during the first lockdown in France suggests the rate of #COVID19 infection was low at 3.7%. Read the @LancetChildAdol study: https://t.co/56qnzdKo14 pic.twitter.com/O2mcnqE42S
— The Lancet (@TheLancet) February 9, 2021
How to vaccinate the world against covid-19
10 Feb, 2021 | 01:49h | UTCHow to vaccinate the world against covid-19 – The BMJ
What if we never reach herd immunity?
10 Feb, 2021 | 01:46h | UTCWhat If We Never Reach Herd Immunity? – The Atlantic
Related: We May Never Get to Herd Immunity – Think Global Health
Coronavirus vaccine strategy needs rethink after resistant variants emerge, say scientists
9 Feb, 2021 | 01:38h | UTCRelated: South Africa halts AstraZeneca vaccine rollout over new variant – BBC AND ‘What other variants might be out there?’ An expert on viral evolution on what’s happening with coronavirus mutations – STAT AND Covid-19: Oxford vaccine offers less protection against South Africa variant (study and commentaries) AND South Africa suspends use of AstraZeneca’s COVID-19 vaccine after it fails to clearly stop virus variant – Science
Mitigating inequities and saving lives with ICU triage during the COVID-19 pandemic
9 Feb, 2021 | 01:29h | UTC
Survey: Prevalence of and factors associated with nurse burnout in the US
7 Feb, 2021 | 20:51h | UTCPrevalence of and Factors Associated With Nurse Burnout in the US – JAMA Network Open
Commentary: Nurse Burnout Remains an Issue in the United States – HealthDay
Commentary on Twitter
Survey finds over 30% of nurses who left their jobs in 2017 reported burnout; working in the hospital and over 40 hours per week increased the odds of leaving due to burnout. @mkali80 @emoryhealthcare https://t.co/R6TYPtANeZ
— JAMA Network Open (@JAMANetworkOpen) February 4, 2021
Editorial: What went wrong in the global governance of covid-19?
7 Feb, 2021 | 21:27h | UTCWhat went wrong in the global governance of covid-19? – The BMJ
Related: The Five Things to Get Right Before the Next Pandemic – Bloomberg AND International collaboration and covid-19: what are we doing and where are we going? – The BMJ AND Why did the world’s pandemic warning system fail when COVID hit? – Nature AND One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes – Health Policy Watch AND WHO’s Covid warnings were not heeded. Now the world has a new chance to beat the virus – The Guardian
Cohort study: Increased consumption of refined grains linked to higher risk of mortality and major cardiovascular disease events
5 Feb, 2021 | 01:30h | UTCCommentaries: Refined carbs like white bread, pasta, and pastries could increase risk of early death, a study found – Insider AND High intake of refined grains linked to higher risk of heart disease and death – The BMJ
Health in dust belt cities and beyond
5 Feb, 2021 | 01:29h | UTCHealth in dust belt cities and beyond—an essay by Nick Middleton – The BMJ
Commentary on Twitter
Desert dust is associated with morbidity and mortality and has global ramifications. What are its health impacts and how can we mitigate the harms?https://t.co/e2oCKxU2GY#virtualWISH2020 @WISHQatar
— The BMJ (@bmj_latest) February 4, 2021
Opinion: Vaccine Nationalism Harms Everyone and Protects No One
5 Feb, 2021 | 01:45h | UTCVaccine Nationalism Harms Everyone and Protects No One – Foreign Policy
Related: Jeremy Farrar: Until we are all safe, no one is safe. Covid is a global problem – The Guardian AND Covid-19: WHO warns against “vaccine nationalism” or face further virus mutations – The BMJ AND ‘Vaccine nationalism’ threatens global plan to distribute COVID-19 shots fairly – Science AND WHO chief warns against ‘catastrophic moral failure’ in COVID-19 vaccine access – United Nations
Why the WHO won’t call it the ‘U.K. variant’, and you shouldn’t either
5 Feb, 2021 | 01:40h | UTCWhy the WHO won’t call it the ‘U.K. variant’, and you shouldn’t either – CTV News
Related: The world needs a single naming system for coronavirus variants – Nature
WHO: Consecutive drop in new COVID-19 cases ‘encouraging news’
4 Feb, 2021 | 01:37h | UTCConsecutive drop in new COVID-19 cases ‘encouraging news’: WHO – UN News
UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus
4 Feb, 2021 | 01:32h | UTCCommentary: Covid: Antibodies last at least six months in most – BBC
Video (3 min): Sinovac and Sinopharm – what do we know about the Chinese vaccines?
4 Feb, 2021 | 01:31h | UTCSinovac and Sinopharm – what do we know about the Chinese vaccines? – BBC
The COVID-19 vaccine in pregnancy: risks, benefits, and recommendations
4 Feb, 2021 | 01:30h | UTCRelated: Pregnancy, breastfeeding and the SARS-CoV-2 vaccine: an ethics-based framework for shared decision-making AND The Coronavirus Vaccine Presents a Dilemma for Pregnant Women – The New Yorker
Russia’s Sputnik V COVID-19 vaccine candidate appears safe and is 91.6% effective
3 Feb, 2021 | 01:49h | UTCCommentaries: Sputnik V COVID-19 vaccine candidate appears safe and effective – The Lancet AND Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results – Health Policy Watch AND Russia’s COVID vaccine 92% effective, even in those over 60 – CIDRAP AND Russia’s Sputnik V vaccine has 92% efficacy in trial – BBC AND Expert reaction to study looking at preliminary efficacy and safety results from interim analysis of Russian COVID-19 phase 3 vaccine (Sputnik) trial – Science Media Centre
Commentary on Twitter
NEW—Interim analysis of Russian #COVID19 #vaccine phase 3 trial involving nearly 20,000 participants suggests a two-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. No serious adverse events were deemed to be associated with vaccination. https://t.co/40sM7f2nbS pic.twitter.com/Hzrs34uCWr
— The Lancet (@TheLancet) February 2, 2021
Editorial: Coronavirus is in the air — there’s too much focus on surfaces
3 Feb, 2021 | 01:40h | UTCCoronavirus is in the air — there’s too much focus on surfaces – Nature
Related: COVID-19 rarely spreads through surfaces. So why are we still deep cleaning? – Nature
Perspective: We may never get to herd immunity
3 Feb, 2021 | 01:37h | UTCWe May Never Get to Herd Immunity – Think Global Health